SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
AMENDMENT NO. 1
TO
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) September 17, 2003
-------------------------------------------------------------------
EXEGENICS INC.
(Exact name of registrant as specified in its charter)
Delaware 00-26078 75-2402409
(State or Other Jurisdiction (Commission File Number) (I.R.S. Employer
of Incorporation) Identification No.)
2110 Research Row
Dallas, Texas 75235
(Address of principal executive
offices including zip code)
(214) 358-2000
(Registrant's telephone number,
including area code)
N.A.
-------------------------------------------------------------
(Former name or former address, if changed since last report)
ITEM 4. CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT
The second paragraph of Item 4 of the Registrant's Current Report on Form 8-K
dated September 19, 2003 is hereby amended and restated to read in its entirety
as follows:
The reports of E&Y on the financial statements of the Registrant as of and for
the fiscal years ended December 31, 2001 and 2002 contained no adverse opinion
or disclaimer of opinion, nor were the reports qualified or modified as to
uncertainty, audit scope or accounting principles. In connection with its audits
for the fiscal years ended December 31, 2001 and December 31, 2002, and during
the subsequent interim period that began on January 1, 2003 and ended on
September 17, 2003, there were no disagreements with E&Y on any matter of
accounting principles or practices, financial statement disclosure, or auditing
scope or procedure, which disagreements, if they had occurred and not been
resolved to the satisfaction of E&Y, would have caused E&Y to make reference to
such disagreements in their reports on the financial statements for such years.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) Exhibits
16.1 Letter from Ernst & Young LLP to the Securities and Exchange
Commission dated September 24, 2003
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
EXEGENICS INC.
(Registrant)
Dated: September 24, 2003 By: /s/ Ronald L. Goode
------------------------------
Ronald L. Goode
Chairman, President and Chief
Executive Officer
INDEX TO EXHIBITS
Exhibit
Number Description
------- -----------
16.1 Letter from Ernst & Young LLP to the Securities and
Exchange Commission dated September 24, 2003